Recent News

• 08.11.2025 - Sonnet Releases Virtual Investor "What This Means" Segment
• 08.04.2025 - Sonnet BioTherapeutics Expands Clinical Evaluation of SON-1010 Dose Escalation with Atezolizumab in Ovarian Cancer
• 07.14.2025 - Sonnet BioTherapeutics, Inc. Announces $888 Million Business Combination to Launch a HYPE Cryptocurrency Treasury Reserve Strategy

Recent Filings

• 08.01.2025 - 8-K Current report
• 07.25.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 07.25.2025 - 8-K Current report
• 07.18.2025 - 8-K Current report
• 07.15.2025 - 4 Statement of changes in beneficial ownership of securities
• 07.15.2025 - 4 Statement of changes in beneficial ownership of securities
• 07.15.2025 - 4 Statement of changes in beneficial ownership of securities
• 07.15.2025 - 4 Statement of changes in beneficial ownership of securities
• 07.15.2025 - 4 Statement of changes in beneficial ownership of securities
• 07.15.2025 - 4 Statement of changes in beneficial ownership of securities